These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36429996)

  • 1. In Schizophrenia, the Effects of the IL-6/IL-23/Th17 Axis on Health-Related Quality of Life and Disabilities Are Partly Mediated by Generalized Cognitive Decline and the Symptomatome.
    Al-Musawi AF; Al-Hakeim HK; Al-Khfaji ZA; Al-Haboby IH; Almulla AF; Stoyanov DS; Maes M
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interleukin-6/interleukin-23/T helper 17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: A precision nomothetic psychiatry analysis.
    Al-Hakeim HK; Al-Musawi AF; Al-Mulla A; Al-Dujaili AH; Debnath M; Maes M
    PLoS One; 2022; 17(10):e0275839. PubMed ID: 36256663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia.
    Kanchanatawan B; Sriswasdi S; Maes M
    Metab Brain Dis; 2019 Feb; 34(1):267-282. PubMed ID: 30467771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life.
    Maes M; Kanchanatawan B
    CNS Spectr; 2021 Apr; ():1-10. PubMed ID: 33843548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity.
    Maes M; Andrés-Rodríguez L; Vojdani A; Sirivichayakul S; Barbosa DS; Kanchanatawan B
    CNS Neurol Disord Drug Targets; 2023; 22(2):215-225. PubMed ID: 35946099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach.
    Maes M; Sirivichayakul S; Matsumoto AK; Michelin AP; de Oliveira Semeão L; de Lima Pedrão JV; Moreira EG; Barbosa DS; Carvalho AF; Solmi M; Kanchanatawan B
    Mol Neurobiol; 2020 Nov; 57(11):4578-4597. PubMed ID: 32754898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways.
    Maes M; Al-Rubaye HT; Almulla AF; Al-Hadrawi DS; Stoyanova K; Kubera M; Al-Hakeim HK
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity.
    Maes M; Sirivichayakul S; Matsumoto AK; Maes A; Michelin AP; de Oliveira Semeão L; de Lima Pedrão JV; Moreira EG; Barbosa DS; Geffard M; Carvalho AF; Kanchanatawan B
    Mol Neurobiol; 2020 May; 57(5):2333-2345. PubMed ID: 32040834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In schizophrenia, immune-inflammatory pathways are strongly associated with depressive and anxiety symptoms, which are part of a latent trait which comprises neurocognitive impairments and schizophrenia symptoms.
    Almulla AF; Al-Rawi KF; Maes M; Al-Hakeim HK
    J Affect Disord; 2021 May; 287():316-326. PubMed ID: 33812245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia.
    Maes M; Vojdani A; Sirivichayakul S; Barbosa DS; Kanchanatawan B
    Mol Neurobiol; 2021 Jul; 58(7):3319-3334. PubMed ID: 33675500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: A systematic review and meta-analysis.
    Patlola SR; Donohoe G; McKernan DP
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110668. PubMed ID: 36283512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.
    Kanchanatawan B; Maes M
    CNS Neurol Disord Drug Targets; 2018; 17(6):473-486. PubMed ID: 29968545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to Construct a Bottom-Up Nomothetic Network Model and Disclose Novel Nosological Classes by Integrating Risk Resilience and Adverse Outcome Pathways with the Phenome of Schizophrenia.
    Maes M; Vojdani A; Galecki P; Kanchanatawan B
    Brain Sci; 2020 Sep; 10(9):. PubMed ID: 32957709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia.
    Al-Hakeim HK; Almulla AF; Al-Dujaili AH; Maes M
    Curr Top Med Chem; 2020; 20(9):747-758. PubMed ID: 31994463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowered serum cesium levels in schizophrenia: association with immune-inflammatory biomarkers and cognitive impairments.
    Almulla AF; Moustafa SR; Al-Dujaili AH; Al-Hakeim HK; Maes M
    Braz J Psychiatry; 2021; 43(2):131-137. PubMed ID: 32556004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?
    González-Blanco L; García-Portilla MP; García-Álvarez L; de la Fuente-Tomás L; Iglesias García C; Sáiz PA; Rodríguez-González S; Coto-Montes A; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(1):9-16. PubMed ID: 29724678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
    Savilla K; Kettler L; Galletly C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in individuals with attenuated psychotic symptoms: Possible role of anxiety, depressive symptoms, and socio-cognitive impairments.
    Takahashi T; Higuchi Y; Komori Y; Nishiyama S; Nakamura M; Sasabayashi D; Nishikawa Y; Sumiyoshi T; Suzuki M
    Psychiatry Res; 2017 Nov; 257():431-437. PubMed ID: 28837932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates.
    Mousa RF; Al-Hakeim HK; Alhaideri A; Maes M
    Metab Brain Dis; 2021 Jan; 36(1):169-183. PubMed ID: 32965599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.